Yaz Lawsuit Updates

Richard Vosser, a JPMorgan Chase & Co. analyst, predicts that the Bayer corporation may have to pay more than $2.65 billion to resolve all the cases over its Yasmin line of birth control pills, Bloomberg reports.

Vosser made his prediction after the German drug-maker settled 651 cases over allegations that the contraceptives caused blood clots, some of which were fatal. In its Stockholders Newsletter, the company said it paid $142 million ...

In a piece for Bakersfield.com, hospital volunteer Bob Jones writes about his harrowing experience with deep-vein thrombosis. Jones’ DVT — a condition that occurs when a blood clot forms in one of the larger, deeper veins – developed into pulmonary embolism when clots traveled to his lungs and nearly killed him.

Jones said his symptoms began with sudden shortness of breath, pain and tightness in his chest, and excessive fatigue and ...

The FDA ordered Bayer, maker of the Yasmin line of birth control pills, to create TV commercials specifically for the purpose of correcting misinformation included in previous ads.

According to Rick’s Blog, Bayer executives used the occasion to produce a spoof ad intended to be shown only in-house, ridiculing birth control pill users as irresponsible and promiscuous.

The blog provides some background on the situation, noting that more than 6,800 lawsuits have ...

An entry on the blog for Cosmopolitan warns readers of a recent announcement by the U.S. Food and Drug Administration that Yasmin, Yaz, Beyaz, Safyral, Ocella and other oral contraceptives containing the compound drospirenone ...

According to Bloomberg, a former director of the U.S. Food and Drug Administration reported that pharmaceutical maker Bayer withheld company research indicating that its Yasmin line of birth control pills caused increased blood clots.

David Kessler, the former FDA commissioner, made those allegations in a report unsealed as part of the ongoing litigation on behalf of patients claiming to be injured by the contraceptives, Bloomberg reports.

It quotes Kessler as saying: “Bayer ...

The Court of Common Pleas in Philadelphia has delayed trial deadlines in the cases over Yaz/Yasmin/Beyaz birth control for another 60 days, extending them until July 9.

Judge Sandra Moss announced the latest extension on April 25, 2012. She’d previously announced a delay on March 9, 2012. This will allow the parties in the case more time to negotiate.

Lopez McHugh is representing multiple plaintiffs against Bayer Healthcare, manufacturer of the birth control pills read more.... --> continue reading...